TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
71.23
+2.37 (3.44%)
At close: Jul 6, 2026, 4:00 PM EDT
72.24
+1.01 (1.42%)
After-hours: Jul 6, 2026, 7:58 PM EDT

TransMedics Group Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, TransMedics Group stock has a consensus rating of "Buy" and an average price target of $117.33. The average 1-year stock price forecast is 64.72% higher than the current stock price, while the lowest is $80 (+12.31%) and the highest is $142 (+99.35%).

Price Target: $117.33 (+64.72%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$80$117.33$120$142
Change+12.31%+64.72%+68.47%+99.35%

Analyst Ratings

The average analyst rating for TransMedics Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy777666
Buy222222
Hold322333
Sell000000
Strong Sell000000
Total121111111111

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Evercore ISI
Evercore ISI
Buy
Maintains
$100$90
BuyMaintains$100$90+26.35%Jul 6, 2026
William Blair
William Blair
Buy
Maintains
n/a
BuyMaintainsn/an/aJul 1, 2026
TD Cowen
TD Cowen
Buy
Maintains
$120
BuyMaintains$120+68.47%Jul 1, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Reiterates
$124
BuyReiterates$124+74.08%Jun 30, 2026
Stifel Nicolaus
Stifel Nicolaus
Hold
Maintains
$80
HoldMaintains$80+12.31%Jun 26, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
733.65M
from 605.49M
Increased by 21.16%
Revenue Next Year
868.94M
from 733.65M
Increased by 18.44%
EPS This Year
1.97
from 2.63
Decreased by -24.86%
EPS Next Year
3.20
from 1.97
Increased by 62.10%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
30.26M93.46M241.62M441.54M605.49M733.65M
Revenue Growth
18.03%208.83%158.53%82.74%37.13%21.16%
Gross Profit
21.16M65.27M154.09M262.08M362.81M433.81M
Gross Margin
69.92%69.84%63.77%59.36%59.92%59.13%
Operating Income
-39.43M-31.44M-1.52M37.50M108.58M102.58M
Net Income
-44.22M-36.23M-25.03M35.46M190.29M75.93M
EPS
----2.631.97
EPS Growth
----160.10%-24.86%
Forward PE
---56.7047.4036.08
Free Cash Flow
-15.66M-45.96M-192.83M-102.77M94.00M9.30M
No. Analysts
-----12
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High741.8M
Avg733.6M
Low728.2M

Revenue Growth

Revenue Growth202620272028
High
22.5%
Avg
21.2%
Low
20.3%

EPS Forecast

EPS202620272028
High2.41
Avg1.97
Low1.63

EPS Growth

EPS Growth202620272028
High
-8.3%
Avg
-24.9%
Low
-37.9%